Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | GPR3 | P46089 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.52 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | GABRP | O00591 | 3/20 | 0.50 |
| ▸ | GABRD | O14764 | 3/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.50 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.50 |
| ▸ | GABRE | P78334 | 3/20 | 0.50 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11647789 | 0.85 | PARP1 (0.61) | ALDH1A1GPR3HSD17B10KMT2AKDM4E | |
| SCHEMBL11981337 | 0.84 | KDM4E (0.64) | ALDH1A1GPR3HSD17B10KMT2AKDM4E | |
| SCHEMBL11981427 | 0.84 | ALDH1A1 (0.50) | ALDH1A1GPR3HSD17B10IMPDH2IMPDH1 | |
| SCHEMBL24425573 | 0.82 | GABRP (0.49) | ALDH1A1GPR3HSD17B10KMT2AKDM4E | |
| SCHEMBL20712203 | 0.82 | CCNB2 (0.59) | ALDH1A1GPR3HSD17B10KMT2AGABRP | |
| SCHEMBL24425669 | 0.82 | CCNE2 (0.60) | ALDH1A1KMT2AKDM4EGABRPGABRD | |
| SCHEMBL15131696 | 0.80 | KDM4E (0.67) | ALDH1A1GPR3HSD17B10KMT2AKDM4E | |
| SCHEMBL1635466 | 0.78 | ALDH1A1 (0.68) | ALDH1A1GPR3HSD17B10IMPDH2IMPDH1 | |
| SCHEMBL30741432 | 0.78 | CHEK1 (0.65) | ALDH1A1GPR3HSD17B10IMPDH2IMPDH1 | |
| SCHEMBL29380761 | 0.78 | ALDH1A1 (0.68) | ALDH1A1GPR3HSD17B10IMPDH2IMPDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479861-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-11-25 | — | — | US | claimed |
| US-20240246999-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-25 | — | — | US | claimed |
| US-11716899-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | claimed |
| US-20210210700-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-07-08 | — | — | US | claimed |
| US-20260062424-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIV DISPLAY CORPORATION (US) | 2026-03-05 | — | — | US | disclosed |
| US-12479861-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-11-25 | — | — | US | disclosed |
| CN-112707923-B | Organic electroluminescent material and device | 环球展览公司 | 2025-06-03 | — | — | CN | disclosed |
| US-20240246999-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-25 | — | — | US | disclosed |
| US-11919914-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-03-05 | — | — | US | disclosed |
| US-11825744-B2 | Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| US-11716899-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-20230006146-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2023-01-05 | — | — | US | disclosed |
| EP-1331010-A1 | PREVENTIVES AND REMEDIES FOR CENTRAL NERVOUS SYSTEM DISEASES | Takeda Chemical Industries, Ltd. (JP) | 2003-07-30 | — | — | EP | disclosed |
| EP-1310490-A1 | GPR14 ANTAGONIST | Takeda Chemical Industries, Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
| EP-1308513-A1 | USE OF POLYPEPTIDE | Takeda Chemical Industries, Ltd. (JP) | 2003-05-07 | — | — | EP | disclosed |
| US-6534496-B1 | Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or | TAKEDA CHEMICAL INDUSTRIES, INC. (JP) | 2003-03-18 | — | — | US | disclosed |
| US-20020177593-A1 | Agents and crystals for improving excretory potency of urinary bladder | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2002-11-28 | — | — | US | disclosed |
| EP-1118322-A1 | DRUGS FOR IMPROVING VESICAL EXCRETORY STRENGTH | Takeda Chemical Industries, Ltd. (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-5620973-A | CHOLINESTERASE INHIBITOR; ALZHEIMER*S DISEASE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0655451-A1 | Tetracyclic condensed heterocyclic compounds for the treatment of senile dementia | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062424-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, SIGMAR1, OXSR1 | ALDH1A1 3447/4885GPR3 534/4885HSD17B10 3357/4885 |
| US-20020177593-A1 | Agents and crystals for improving excretory potency of urinary bladder | ACHE, BPHL, BCHE | ALDH1A1 1185/4885GPR3 1696/4885HSD17B10 3205/4885 |
| US-11919914-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | ALDH1A1 939/4885GPR3 1688/4885HSD17B10 1484/4885 |
| US-20240246999-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP | ALDH1A1 939/4885GPR3 1688/4885HSD17B10 1484/4885 |
| US-11825744-B2 | Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device | PIEZO1, OCIAD1, AQP1 | ALDH1A1 131/4885GPR3 4041/4885HSD17B10 2110/4885 |
| US-20230006146-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OCIAD2, OCIAD1 | ALDH1A1 1842/4885GPR3 2556/4885HSD17B10 2762/4885 |
| US-12479861-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | ALDH1A1 939/4885GPR3 1688/4885HSD17B10 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.